Lifestyle Medicine and Chronic Kidney Disease in Viet Nam: Evidence, Dietary Safety, Physical Activity and Cardiometabolic Risk
EVIDENCE & CLINICAL PRACTICELIFESTYLE MEDICINE IN VIET NAM


Lifestyle Medicine and Chronic Kidney Disease in Viet Nam: Evidence, Dietary Safety, Physical Activity and Cardiometabolic Risk
Last reviewed: November 7, 2026
Chronic kidney disease is often discussed in terms of declining kidney function. In practice, it is closely connected with hypertension, diabetes, cardiovascular disease, nutritional status, medication safety and a person's ability to remain physically active.
People with chronic kidney disease may face cardiovascular complications long before they develop kidney failure. Others experience progressive fatigue, reduced appetite, muscle loss, anemia or disturbances in potassium, phosphate and fluid balance.
Lifestyle Medicine has a meaningful role in addressing many of these concerns. Healthy dietary patterns, appropriate physical activity, tobacco cessation, weight management and other evidence-based interventions can support cardiovascular and metabolic health, physical function and quality of life.
However, chronic kidney disease is also a condition in which seemingly healthy recommendations can become inappropriate when applied without sufficient clinical assessment.
A high-protein diet may not be suitable for someone with progressive kidney disease. A potassium-containing salt substitute may create additional risk for a patient with hyperkalemia. Drinking excessive amounts of water may be harmful when fluid excretion is impaired. Conversely, unnecessary restriction of food or protein can contribute to malnutrition and muscle loss.
These examples illustrate an important principle: there is no single Lifestyle Medicine diet or exercise prescription suitable for everyone with chronic kidney disease.
Appropriate care depends on the cause and severity of kidney disease, albuminuria, laboratory findings, nutritional status, medications, complications and other medical conditions.
For Viet Nam, the opportunity is to integrate evidence-based lifestyle interventions into existing kidney and cardiometabolic care while ensuring that nutritional and clinical decisions remain individualized, safe and professionally appropriate.
Why Chronic Kidney Disease Matters in Viet Nam
Chronic kidney disease is a growing global health concern, particularly because it is frequently undetected in its earlier stages and substantially increases cardiovascular risk.
In April 2026, the World Health Organization published an updated fact sheet on kidney disease, emphasizing the importance of early detection, prevention of progression and integration of kidney care with management of hypertension, diabetes and cardiovascular disease.
The organization highlighted that chronic kidney disease can often be identified in primary care through relatively accessible investigations, including serum creatinine measurement to estimate kidney filtration and urine testing for albuminuria.
For Viet Nam, understanding the burden of chronic kidney disease remains challenging because comprehensive, nationally representative prevalence data are limited.
A population-based study conducted in Can Tho City in 2023 and published in the Canadian Journal of Kidney Health and Disease in January 2025 provides useful local evidence.
The study included 1,490 adults and assessed kidney function and albuminuria, including repeat testing after three months.
Chronic kidney disease was identified in 13.1% of participants. Increasing age, hypertension and diabetes were associated with higher odds of chronic kidney disease.
These findings are relevant, but the study was conducted in one city. The reported prevalence should not be presented as a national estimate for Viet Nam.
The findings nevertheless illustrate why kidney health deserves attention within prevention and long-term management of noncommunicable diseases.
Many people with chronic kidney disease have few noticeable symptoms until the condition becomes more advanced. Earlier detection creates opportunities to address kidney and cardiovascular risk before complications become more difficult to manage.
However, diagnosis must be appropriate. A single abnormal creatinine measurement does not necessarily establish chronic kidney disease.
Kidney Disease Must Be Classified Before Dietary Advice Is Individualized
The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease remains the principal international reference for this review.
It emphasizes classification according to three elements: the underlying cause of kidney disease, the level of glomerular filtration and the degree of albuminuria.
Chronic kidney disease is generally defined by abnormalities of kidney structure or function that persist for at least three months and have implications for health.
The estimated glomerular filtration rate is used to categorize kidney function.
Categories G1 and G2 refer to estimated filtration rates of at least 90 and 60–89 mL/min/1.73 m², respectively. These categories do not, by themselves, establish chronic kidney disease when other markers of kidney damage are absent.
Category G3a represents an estimated filtration rate of 45–59 mL/min/1.73 m², while G3b represents 30–44. Category G4 covers 15–29, and G5 refers to an estimated filtration rate below 15 mL/min/1.73 m².
Albuminuria provides another important dimension of risk.
The KDIGO framework uses category A1 for a urine albumin-to-creatinine ratio below 30 mg/g, A2 for 30–299 mg/g and A3 for 300 mg/g or higher.
A person with relatively preserved filtration but significant albuminuria may face substantial kidney and cardiovascular risk. Another person with reduced filtration and little albuminuria may have a different prognosis and clinical needs.
Consequently, decisions should not be based on the estimated glomerular filtration rate alone.
The cause of kidney disease also matters. Diabetic kidney disease, glomerular disease, inherited kidney conditions and other causes may require different diagnostic and therapeutic approaches.
For Lifestyle Medicine, classification is important because it determines which interventions are relevant, which risks require attention and how closely the patient should be monitored.
A dietary recommendation appropriate for stable early-stage disease may be unsuitable for someone with advanced kidney disease, recurrent hyperkalemia or significant nutritional impairment.
Nutritional Priorities Change Across Disease Stages
A major mistake in public health communication is to treat chronic kidney disease as though everyone needs the same restricted diet.
In earlier stages, when kidney function is relatively preserved and laboratory results are stable, dietary priorities may focus on reducing excessive sodium, improving overall dietary quality, managing relevant cardiometabolic risk and avoiding unnecessary protein excess.
Patients with diabetes or hypertension may benefit from interventions that support appropriate blood-pressure and glucose control.
However, even early-stage patients require individualized assessment when albuminuria is substantial, the underlying kidney disease is active or other complications are present.
As kidney function declines, nutrition becomes more complex.
In stages G3a and G3b, clinicians may need to consider the patient's protein intake, nutritional status, potassium, medications and relevant metabolic complications more closely.
In stages G4 and G5, particularly when kidney failure is approaching, disturbances in potassium, phosphate, acid-base balance and fluid regulation may become more important. Reduced appetite, malnutrition, anemia and muscle loss can also influence dietary decisions.
These complications do not develop in every patient or at identical stages. Their presence must be established through appropriate assessment.
The situation changes again for people receiving maintenance dialysis.
Dialysis can increase protein losses and alter nutritional requirements. Some people also require individualized restrictions involving fluid, sodium, potassium or phosphorus, depending on dialysis modality, residual kidney function, laboratory results and other factors.
Patients who have received a kidney transplant have additional considerations involving graft function, immunosuppressive treatment, infection prevention and long-term metabolic risk.
Children, pregnant patients and frail older adults also have nutritional requirements that differ from those of typical adults with stable chronic kidney disease.
The practical lesson is that disease stage provides important context, but nutritional treatment must also account for complications, treatment modality and the individual person's circumstances.
There Is No Single Kidney Diet
KDIGO 2024 encourages people with chronic kidney disease to follow healthy, diverse dietary patterns with a greater proportion of plant-based foods relative to animal-based foods and lower consumption of ultra-processed foods.
This is consistent with the emphasis on dietary quality within Lifestyle Medicine.
However, the guideline also calls for individualized adaptation of protein, sodium, potassium and phosphorus intake according to kidney disease severity, associated conditions and nutritional requirements.
A plant-predominant eating pattern does not mean that every patient should adopt an unrestricted vegan diet.
Nor does it mean that fruits, vegetables, legumes and whole grains must automatically be avoided because they contain potassium or phosphorus.
The appropriate dietary pattern depends on the patient's laboratory results, overall nutritional needs, medications and ability to maintain adequate intake.
For Vietnamese patients, dietary advice can often be built around familiar foods rather than imported products marketed as kidney-friendly.
Vegetables, suitable fruits, tofu, beans, rice, grains, fish and other protein sources may all be included where appropriate.
What matters is not whether an individual food is labeled healthy or unhealthy in isolation.
The more useful question is how the overall dietary pattern fits the person's kidney function, metabolic condition, nutritional status and treatment plan.
This is why kidney-specific nutrition counseling should not be reduced to distributing a universal food list.
Protein Intake Requires Balance, Not Automatic Restriction
Protein is one of the most important areas requiring individualized nutritional assessment.
High-protein diets have become increasingly popular in weight management, fitness and healthy aging. However, excessive protein intake may be inappropriate for some people with chronic kidney disease.
KDIGO 2024 suggests maintaining protein intake at approximately 0.8 grams per kilogram of body weight per day in adults with chronic kidney disease stages G3–G5.
It also advises avoiding high protein intake exceeding 1.3 grams per kilogram per day in adults at risk of kidney disease progression.
These recommendations are not intended as a universal formula for everyone with kidney disease.
They apply within a defined clinical context and require consideration of nutritional status, metabolic stability, body composition and other health conditions.
Selected adults at risk of kidney failure may be considered for a more restrictive protein regimen under close specialist supervision. Such approaches require careful nutritional planning and are not appropriate for unsupervised self-management.
The opposite problem is excessive restriction.
Low-protein diets may contribute to inadequate nutrition when energy intake is insufficient or when a patient already has poor appetite, unintended weight loss or muscle wasting.
KDIGO specifically advises against low- or very-low-protein diets in metabolically unstable patients.
Frail older adults and people with sarcopenia may require higher protein and energy targets to preserve nutritional status and function.
People receiving maintenance dialysis generally need more protein than those with non-dialysis chronic kidney disease.
The American Diabetes Association's Standards of Care in Diabetes 2026 also recommend approximately 0.8 grams of protein per kilogram of body weight per day for people with chronic kidney disease stage G3 or higher who are not receiving dialysis, while considering approximately 1.0–1.2 grams per kilogram per day for individuals on dialysis.
These recommendations must be interpreted in the context of the patient's treatment, nutritional status and clinical condition.
In children, protein restriction can interfere with growth and requires a fundamentally different approach.
For patients with diabetes, restrictive diets should also be coordinated with glucose-lowering treatment when substantial changes in food intake could affect medication safety.
The objective is not to minimize protein at any cost. It is to provide an appropriate amount while preserving adequate energy intake, muscle mass and physical function.
Sodium Reduction Is Important, Especially in the Vietnamese Diet
Reducing excessive sodium intake is one of the most broadly relevant dietary interventions in chronic kidney disease.
KDIGO 2024 suggests sodium intake below 2 grams per day, equivalent to approximately 5 grams of sodium chloride, for many people with chronic kidney disease.
This is a general guideline recommendation, not an individualized prescription for every patient. Certain conditions, including sodium-wasting kidney disorders, require different approaches.
Sodium reduction can support blood-pressure management and may help reduce fluid-related problems in appropriate patients.
In Viet Nam, the challenge extends beyond adding salt during cooking.
Fish sauce, soy sauce, seasoning powders, instant noodles, preserved foods, processed meats and fish products, packaged sauces and restaurant meals can all contribute substantially to sodium intake.
Some patients may reduce visible table salt while continuing to consume considerable sodium through condiments and processed foods.
A more useful approach involves understanding how meals are prepared and consumed.
Small changes in the quantity and frequency of high-sodium condiments may be more practical than asking patients to eliminate familiar dishes entirely.
Food labels can also help, although sodium content may be reported in different serving sizes and requires careful interpretation.
Salt substitutes deserve particular caution.
Some products marketed as low-sodium salts contain potassium chloride. These products may be suitable for certain individuals but can create serious problems for patients with hyperkalemia or impaired potassium excretion.
The presence of chronic kidney disease, relevant medications and laboratory results should therefore be considered before recommending potassium-containing salt substitutes.
Lower sodium does not automatically mean safer for every kidney patient.
Potassium: Individualized Assessment Is Better Than Blanket Food Restrictions
Potassium management is one of the most frequently misunderstood aspects of kidney nutrition.
Patients are sometimes advised to avoid bananas, oranges, tomatoes, potatoes, beans and many vegetables simply because they have chronic kidney disease.
This can unnecessarily reduce dietary variety and fiber intake, particularly when serum potassium is normal and no other relevant risk factors are present.
KDIGO 2024 recommends an individualized approach for people with chronic kidney disease stages G3–G5 who develop hyperkalemia.
The assessment should consider kidney function, current potassium concentration, previous episodes of hyperkalemia, medications, other medical conditions and dietary intake.
Some medicines can increase serum potassium, including certain renin-angiotensin system inhibitors and mineralocorticoid receptor antagonists.
Metabolic acidosis, uncontrolled hyperglycemia, constipation and declining kidney function may also contribute to potassium abnormalities.
Potassium from different food sources is not absorbed equally.
Potassium additives in processed foods and potassium chloride in salt substitutes may be highly bioavailable, while potassium contained in many minimally processed plant foods is absorbed differently.
This distinction supports a more nuanced approach than simply identifying foods with high total potassium content.
When hyperkalemia is present or the risk is increased, targeted dietary modification may be appropriate. Assessment by a renal dietitian or another appropriately qualified nutrition professional can help preserve nutritional quality while addressing the clinical problem.
Patients with normal potassium concentrations should not automatically be placed on highly restrictive diets solely because of their chronic kidney disease diagnosis.
It is also important to recognize that potassium can be too low.
Some patients, including those using particular diuretics or experiencing gastrointestinal losses, may develop hypokalemia rather than hyperkalemia.
Both abnormalities can have serious consequences.
Patients should not attempt to correct abnormal potassium results through unsupervised dietary restriction, potassium supplements or salt substitutes.
Significant potassium abnormalities require clinical interpretation and, when appropriate, timely treatment.
Phosphorus Management Depends on Biochemical and Clinical Findings
Phosphorus is another nutrient that should not be restricted indiscriminately.
As kidney function declines, some patients develop disturbances involving phosphate, calcium, parathyroid hormone and bone metabolism.
These abnormalities are considered within the framework of chronic kidney disease–mineral and bone disorder.
The KDIGO 2017 guideline update on chronic kidney disease–mineral and bone disorder recommends basing decisions about phosphate-lowering treatment on progressively or persistently elevated serum phosphate rather than an isolated measurement.
It also supports considering the source of dietary phosphorus when advising patients with hyperphosphatemia.
Phosphorus additives in processed foods and beverages are often more readily absorbed than phosphorus naturally present in certain plant foods.
Consequently, reducing highly processed foods containing phosphate additives may be more useful than automatically excluding nutritious foods such as legumes or whole grains.
The appropriate intervention must also consider protein requirements.
A patient who restricts multiple protein-containing foods to reduce phosphorus intake may unintentionally develop inadequate protein and energy intake.
For someone with advanced kidney disease, preserving nutritional status while managing elevated phosphate may require coordinated dietary counseling and medical treatment.
Phosphate binders may be indicated in selected patients, but their use is a medical treatment decision rather than a general Lifestyle Medicine recommendation.
Phosphorus advice should therefore be guided by laboratory trends, nutritional status, disease stage and the overall treatment plan.
Fluid Intake: More Water Is Not Always Better
Advice to drink more water is common in general health promotion.
For people with chronic kidney disease, however, fluid requirements vary substantially.
Many people with earlier-stage chronic kidney disease do not need routine fluid restriction. Adequate hydration remains important, particularly when dehydration could contribute to acute kidney injury.
At the same time, increasing fluid intake beyond the body's capacity to excrete it may create problems in patients with advanced kidney disease, heart failure or other conditions affecting fluid balance.
People with kidney failure who produce little urine may develop fluid overload, swelling, elevated blood pressure or breathlessness when fluid intake exceeds their ability to remove excess water.
Patients receiving dialysis may require individualized fluid allowances based on residual urine output, weight changes between treatments, dialysis modality and clinical condition.
Even among dialysis patients, fluid requirements are not identical.
For Vietnamese patients, fluid intake may include not only drinking water, but also soup, broth, tea, coffee and other beverages.
A person following a fluid restriction may need to consider these sources within the prescribed plan.
There is no universal recommendation that every patient with chronic kidney disease should drink a fixed number of liters per day.
Likewise, advising someone to drink as little as possible can be harmful when restriction is not indicated.
Fluid management should reflect kidney function, urine output, hydration status, medications, cardiovascular condition and the presence or absence of fluid overload.
Malnutrition, Muscle Loss and Frailty Must Not Be Overlooked
One of the risks of emphasizing dietary restriction in chronic kidney disease is that inadequate nutrition may go unnoticed.
Patients with more advanced disease can experience reduced appetite, nausea, altered taste, fatigue and difficulty maintaining adequate food intake.
Inflammation, metabolic disturbances, concurrent illness and treatment-related factors may further contribute to malnutrition and muscle loss.
Older adults are particularly vulnerable when reduced food intake is combined with frailty or limited physical activity.
KDIGO 2024 recommends screening people with advanced chronic kidney disease, older patients with increased nutritional risk and individuals with symptoms such as involuntary weight loss, frailty or poor appetite for malnutrition.
It also supports access to appropriate medical nutrition therapy, ideally delivered under the supervision of renal dietitians or accredited nutrition professionals.
Nutritional evaluation should not rely on body weight alone.
Changes in appetite, dietary intake, muscle mass, functional performance and relevant clinical indicators may provide additional information.
A patient can have excess body weight and still experience clinically important loss of muscle.
This has implications for Lifestyle Medicine because programs that emphasize weight loss without assessing nutritional status may inadvertently worsen frailty or physical function.
For some patients, weight reduction is an appropriate part of cardiometabolic risk management.
For others, maintaining weight, preserving muscle and ensuring adequate nutrition may be more important.
The goal should be improved health and function, not weight reduction regardless of clinical circumstances.
Physical Activity Can Support Kidney Health
Physical activity remains relevant to people living with chronic kidney disease.
The potential benefits extend beyond body weight and may include improved cardiovascular fitness, muscle strength, physical function, blood-pressure control and quality of life.
KDIGO 2024 recommends that people with chronic kidney disease undertake moderate-intensity physical activity for a cumulative duration of at least 150 minutes per week, or to a level compatible with their cardiovascular and physical tolerance.
The qualification concerning individual tolerance is essential.
People with chronic kidney disease vary considerably in age, functional capacity, cardiovascular condition, anemia, frailty, fall risk and other medical needs.
A clinically stable adult with early-stage disease may be able to follow a relatively conventional exercise program.
Someone with advanced disease, symptomatic anemia, significant cardiovascular limitations or frailty may require a different starting point, closer monitoring or specialist rehabilitation input.
Walking, cycling, resistance exercise and balance activities may all be appropriate in selected patients.
Exercise does not necessarily require access to a gym or expensive equipment.
For older adults, preserving strength and balance may be particularly important for maintaining independence and reducing fall risk.
For people receiving dialysis, exercise and rehabilitation require additional consideration of treatment schedules, vascular access, symptoms and clinical stability.
A growing evidence base supports physical activity for several functional and cardiovascular outcomes.
A 2024 meta-analysis involving people with pre-dialysis chronic kidney disease found improvements in aerobic capacity, physical performance and selected cardiometabolic measures.
A further systematic review and meta-analysis published in 2026 reported benefits across several physical and health-related outcomes.
However, these findings should not be interpreted as proof that exercise alone reliably prevents kidney failure or reverses established kidney damage.
Studies differ in their populations, intervention protocols, duration and outcomes.
The most appropriate clinical objectives are often improved function, cardiovascular health, symptom management and quality of life.
Exercise should therefore be encouraged when suitable, adapted when necessary and reconsidered when symptoms indicate that additional assessment is required.
Kidney and Cardiovascular Protection Must Be Managed Together
Chronic kidney disease substantially increases cardiovascular risk.
The relationship involves hypertension, diabetes, dyslipidemia, heart failure, vascular disease and abnormalities associated with declining kidney function.
For this reason, monitoring serum creatinine alone provides an incomplete picture of the patient's health.
Blood pressure, albuminuria, glucose control, cardiovascular history, medication use and other relevant factors should be considered together.
KDIGO 2024 emphasizes an integrated approach to kidney and cardiovascular risk management.
The guideline supports appropriate blood-pressure control, treatment of diabetes, tobacco avoidance, physical activity and evidence-based medication use.
Its recommendation concerning systolic blood pressure below 120 mmHg applies to selected adults with high blood pressure and chronic kidney disease when tolerated and measured using standardized office techniques.
This target must not be applied indiscriminately to routine or nonstandardized measurements, or to patients in whom more intensive treatment would create excessive risk.
Clinical decisions should consider symptoms, frailty, falls risk and other relevant factors.
Lifestyle interventions can support blood-pressure and metabolic control, but they do not replace medications with established kidney or cardiovascular benefits.
Renin-angiotensin system inhibitors, sodium-glucose cotransporter-2 inhibitors and other therapies may be indicated according to kidney function, albuminuria, diabetes, heart failure and other clinical considerations.
The American Diabetes Association's 2026 Standards of Care also emphasize the importance of kidney-protective treatments for people with diabetes and chronic kidney disease.
Medication decisions should be individualized and periodically reviewed.
Improvement in diet, weight, blood pressure or glucose control does not automatically mean that kidney-protective medication should be stopped.
Some treatments provide benefits beyond the immediate laboratory parameter being monitored.
Lifestyle interventions and evidence-based pharmacological treatment should work together rather than be presented as competing approaches.
Medication and Supplement Safety Deserve Particular Attention
Medication safety is a major component of chronic kidney disease care.
Reduced kidney function can change how certain medicines are eliminated, while other medicines may increase the risk of acute kidney injury, electrolyte abnormalities or other complications.
The risk is particularly relevant when patients have several chronic conditions, receive multiple prescriptions or use over-the-counter products.
Nonsteroidal anti-inflammatory drugs are an important example.
These medicines may be harmful to kidney function in susceptible patients, especially when combined with dehydration, certain other medications or underlying kidney disease.
Healthcare professionals should also ask about supplements, herbal products, traditional medicines, protein powders and other products that patients may not consider medication.
The fact that a product is described as natural, herbal or kidney-cleansing does not establish that it is safe or effective.
Some products may contain potentially harmful substances, interact with prescribed medicines or impose an inappropriate mineral or metabolic burden.
The appropriate response is not to assume that every traditional product is harmful. It is to assess safety based on available evidence, composition, kidney function and possible interactions.
Significant changes in diet or body weight may also affect treatment requirements.
For example, major dietary changes can influence glucose control in patients receiving medications associated with hypoglycemia. Changes in hydration and sodium intake may affect blood pressure and diuretic management.
Patients receiving medications that influence potassium balance may require monitoring when dietary patterns or treatment regimens change substantially.
Medication initiation, dose adjustment and discontinuation must remain the responsibility of appropriately authorized prescribing professionals.
Patients should not independently stop or change prescribed medicines because they believe their kidney function or lifestyle has improved.
New Guidelines in 2026: What Has Actually Changed?
The KDIGO 2024 guideline remains the current comprehensive international reference for evaluating and managing chronic kidney disease.
However, the evidence base continues to evolve.
In March 2026, KDIGO announced a focused update to its chronic kidney disease guideline, addressing emerging evidence involving sodium-glucose cotransporter-2 inhibitors, glucagon-like peptide-1-based therapies and nonsteroidal mineralocorticoid receptor antagonists.
On October 15, 2026, KDIGO released the public-review draft of the KDIGO 2027 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: Medications Management.
The public consultation closed on November 4, 2026, and the draft remains under revision.
As of this review, that draft should not be treated as a finalized replacement for KDIGO 2024.
A separate and important development occurred on January 2, 2026, when KDIGO published its new Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease.
The updated guideline addresses the evaluation and management of anemia across different stages of kidney disease, including people receiving dialysis and kidney transplantation.
This matters for Lifestyle Medicine because fatigue and reduced exercise tolerance in chronic kidney disease should not automatically be attributed to physical inactivity, poor sleep or insufficient motivation.
Anemia and other medical complications may require specific investigation and treatment.
Likewise, chronic kidney disease–mineral and bone disorder requires appropriate clinical evaluation rather than routine dietary restriction alone.
Lifestyle interventions should be informed by these condition-specific guidelines and integrated with relevant medical care.
When Should Kidney-Specific Nutrition Be Reassessed?
Dietary requirements are not necessarily stable over time.
A patient with relatively preserved kidney function and normal potassium may initially benefit from broad improvements in dietary quality.
If kidney function declines, albuminuria increases or hyperkalemia develops, the nutritional plan may need modification.
Similarly, a patient who begins dialysis may require substantially different protein, fluid and mineral management from the regimen used before dialysis.
Reassessment is also important when medications change, acute illness occurs or nutritional status deteriorates.
KDIGO 2024 recommends assessment of kidney function and albuminuria at least annually in people with chronic kidney disease, with more frequent assessment when the risk of progression is higher or the results are likely to influence clinical decisions.
Patients undergoing significant treatment changes may require additional monitoring of kidney function, potassium or other relevant biochemical measures.
The appropriate interval depends on the clinical condition and intervention.
For people with stage G3–G5 chronic kidney disease, validated kidney failure risk equations can also support decisions about referral and the intensity of follow-up.
KDIGO recognizes that predicted kidney failure risk may help determine when nephrology referral, multidisciplinary care or preparation for kidney replacement therapy should be considered.
These tools should be used within their validated populations and alongside clinical judgment.
Nutrition review should not wait for kidney failure to develop.
Unintended weight loss, poor appetite, recurrent electrolyte abnormalities, deteriorating kidney function or difficulty following a prescribed diet may all justify earlier assessment.
A useful care plan identifies who will review the relevant findings, when reassessment is expected and what changes should trigger additional clinical attention.
Clinical Safety Must Take Priority
Lifestyle recommendations should not delay appropriate assessment or treatment of kidney-related complications.
Rapidly worsening swelling, new or severe breathlessness, marked reduction in urine output, chest pain, confusion, severe weakness or other acute symptoms may require urgent medical evaluation.
Significant potassium abnormalities can be dangerous even when symptoms are limited or absent. Abnormal laboratory results therefore require interpretation according to their severity and clinical context.
Persistent vomiting, dehydration or acute illness may also increase the risk of kidney injury and medication-related complications.
Patients should receive clear instructions about when to contact their healthcare team and when emergency assessment is necessary.
They should not attempt to correct serious laboratory abnormalities using supplements, excessive water intake, fasting or self-directed dietary restriction.
Nor should they independently alter prescribed medication or dialysis arrangements.
Lifestyle Medicine should contribute to safer care by helping professionals recognize risks, support appropriate behavior change and coordinate timely assessment.
It should never substitute general lifestyle advice for the treatment of an acute or potentially serious medical problem.
Clinical Nutrition and Professional Responsibilities in Viet Nam
In Viet Nam, individualized nutrition used to manage disease must be distinguished from general health education.
The Law on Medical Examination and Treatment, reflected in Consolidated Document No. 26/VBHN-VPQH dated February 26, 2026, provides the principal legal framework governing regulated healthcare practice.
Article 67 addresses nutrition in medical examination and treatment, including clinical nutrition, nutritional assessment, disease-related dietary counseling, monitoring and education.
The law also recognizes clinical nutrition as a regulated professional title requiring a practice license.
Article 120 provides that the National Medical Council begins competency assessment for clinical nutrition and certain other professional categories from January 1, 2029.
This is the implementation date for the relevant competency assessment requirement. It does not mean that clinical nutrition first becomes a regulated professional field in 2029.
For hospitals, Circular No. 18/2020/TT-BYT on nutrition activities in hospitals remains partly in force.
Circular No. 08/2024/TT-BYT repealed Articles 6 and 8 of Circular No. 18/2020/TT-BYT, while its other applicable provisions continue to govern relevant hospital nutrition activities.
Article 2 requires nutrition activities to be integrated with hospital medical care, provides for nutritional risk screening and assessment, and requires dietary regimens to reflect the patient's nutritional and medical condition.
It also establishes that the treating physician or a physician in the nutrition department determines the patient's dietary regimen.
For chronic kidney disease, these provisions reinforce the importance of clinical governance and professional responsibilities.
General education about healthy dietary patterns may be suitable for broad audiences.
However, individualized decisions concerning substantial protein restriction, potassium or phosphorus modification, fluid restriction and other kidney-specific therapeutic nutrition require appropriate clinical assessment.
Where nutritional needs are complex, referral to a renal dietitian or another appropriately qualified clinical nutrition professional is important.
International certifications in Lifestyle Medicine, nutrition or health coaching do not independently authorize regulated clinical activities beyond the practitioner's legally permitted scope.
Public education should therefore avoid presenting a universal chronic kidney disease meal plan as appropriate for unsupervised use.
What Should Healthcare Organizations in Viet Nam Do Differently?
For many healthcare organizations, improving chronic kidney disease care does not require establishing a separate Lifestyle Medicine clinic.
A more practical approach is to strengthen existing care pathways.
Patients with diabetes, hypertension or other relevant risk factors can receive appropriate kidney assessment based on established clinical guidance.
Where chronic kidney disease is identified, healthcare professionals can consider its cause, filtration category, albuminuria, complications, nutritional status and cardiovascular risk.
Lifestyle assessment can then examine dietary patterns, physical activity, tobacco and alcohol exposure, sleep, social circumstances and other relevant factors.
The results should be integrated with kidney-specific clinical information rather than treated as a separate wellness assessment.
For some patients, reducing sodium and improving dietary quality may be appropriate initial priorities.
Others may require targeted management of potassium, phosphorus, fluid balance or protein intake.
Patients with malnutrition, frailty or advanced kidney disease may need specialist nutritional assessment and closer monitoring.
Medication and supplement review should be integrated with the care plan.
Appropriate referral is important when the patient's needs exceed the capability of the initial service.
Healthcare organizations can also evaluate whether these processes are functioning effectively.
Useful measures may include appropriate assessment of kidney function and albuminuria, recognition of nutritional risk, completion of relevant referrals, management of cardiovascular risk, documentation of individualized dietary recommendations and monitoring of medication-related safety concerns.
Patient-reported outcomes and quality of life also deserve attention.
The objective should not simply be to record that patients were advised to eat healthier and exercise.
It should be to determine whether the care process has become safer, more coordinated and more useful to patients.
The Role of Lifestyle Medicine Is Individualization, Not Another Restrictive Diet
Chronic kidney disease illustrates why Lifestyle Medicine requires more than knowledge of healthy behaviors.
A recommendation that is beneficial for the general population may need modification when kidney function, nutritional status or treatment requirements change.
For one patient, reducing sodium and improving cardiovascular risk may be the main priorities.
For another, the immediate challenge may be recurrent hyperkalemia, fluid overload or deteriorating nutritional status.
A patient receiving dialysis may need a higher protein intake than someone with non-dialysis chronic kidney disease.
An older adult with frailty may require greater emphasis on preserving muscle and function, while a younger person with obesity and diabetes may benefit from appropriately supervised weight management.
These are not competing approaches.
They reflect the need to match interventions to clinical circumstances.
The strongest contribution of Lifestyle Medicine is therefore not to introduce a particular kidney diet or promise that dietary modification can reverse established kidney damage.
It is to help healthcare professionals address modifiable risk factors while ensuring that nutrition, physical activity, medication management and other interventions remain evidence-based, individualized and appropriately monitored.
For Viet Nam, this means strengthening early recognition of kidney risk, connecting kidney care with diabetes and hypertension management, adapting nutrition advice to Vietnamese food culture and improving access to appropriate professional support.
The central question should not be, “What foods should everyone with kidney disease avoid?”
It should be, “What dietary pattern, level of activity and clinical treatment are safest and most appropriate for this person's kidney function, complications, nutritional status and overall health?”
That is a more reliable foundation for integrating Lifestyle Medicine into chronic kidney disease care.
References and Further Reading
Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4 Suppl)–S314. doi:10.1016/j.kint.2023.10.018.
Kidney Disease: Improving Global Outcomes. CKD Evaluation and Management: Current Guideline Status and Focused Update. Updated 2026.
Kidney Disease: Improving Global Outcomes. KDIGO 2027 CKD Guideline Focused Update: Public Review Open. October 15, 2026.
Kidney Disease: Improving Global Outcomes. KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease. Kidney International. 2026;109(Suppl 1S)–S99. doi:10.1016/j.kint.2025.06.006.
Kidney Disease: Improving Global Outcomes. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder. Kidney International Supplements. 2017;7(1):1–59. doi:10.1016/j.kisu.2017.04.001.
World Health Organization. Kidney Disease. Fact sheet. April 20, 2026.
Vo NH, Pham BV, Nguyen NN, Nguyen BT. A Predictive Nomogram for Selective Screening of Chronic Kidney Disease: A Population-Based Study. Canadian Journal of Kidney Health and Disease. 2025;12. doi:10.1177/20543581241309979.
American Diabetes Association Professional Practice Committee for Diabetes. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes, 2026. Diabetes Care. 2026;49(Suppl 1). doi:10.2337/dc26-S011.
Neale EP, Do Rosario V, Probst Y, Beck E, Tran TB, Lambert K. Lifestyle Interventions, Kidney Disease Progression, and Quality of Life: A Systematic Review and Meta-analysis. Kidney Medicine. 2023;5(6):100643. doi:10.1016/j.xkme.2023.100643.
Traise A, Dieberg G, Pearson MJ, Smart NA. The Effect of Exercise Training in People With Pre-dialysis Chronic Kidney Disease: A Systematic Review With Meta-analysis. Journal of Nephrology. 2024;37(8):2063–2098. doi:10.1007/s40620-024-02081-9.
Chen Y, Ren S, Yao X, et al. Benefits of Physical Exercises in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Renal Failure. 2026;48(1):2654288. doi:10.1080/0886022X.2026.2654288.
National Kidney Foundation. How to Plan Meals for Chronic Kidney Disease. Patient education resource. 2026.
National Kidney Foundation. Healthy Hydration and Your Kidneys. Patient education resource.
Office of the National Assembly of Viet Nam. Consolidated Document No. 26/VBHN-VPQH, Law on Medical Examination and Treatment. February 26, 2026.
Ministry of Health of Viet Nam. Circular No. 18/2020/TT-BYT on Nutrition Activities in Hospitals. November 12, 2020, as applicable following subsequent partial repeal.
Ministry of Health of Viet Nam. Circular No. 08/2024/TT-BYT Partially Repealing Legal Documents Issued by the Minister of Health. May 24, 2024.
Rea BL, Cheema S, Lanza S, et al. Lifestyle Medicine Core Competencies: 2025 Update. American Journal of Lifestyle Medicine. 2026;20(3):443–451. First published online October 28, 2025. doi:10.1177/15598276251379821.
Educational and Clinical Governance Note
This article is intended for professional education, general information and scientific knowledge exchange. It does not constitute an individualized kidney treatment plan, dietary prescription, exercise prescription, medication recommendation, dialysis management plan or authoritative interpretation of Vietnamese law.
Dietary recommendations for people with chronic kidney disease must be individualized according to kidney function, albuminuria, disease stage, treatment modality, laboratory findings, nutritional status, medications, complications and other relevant clinical circumstances.
Patients should not independently initiate substantial protein restriction, potassium or phosphorus restriction, fluid restriction, potassium-containing salt substitutes, supplements, restrictive diets or major changes in physical activity without appropriate professional assessment.
Prescribed medication, dialysis arrangements and other regulated medical treatments should not be stopped, reduced, increased or otherwise changed without review and direction from appropriately qualified and legally authorized healthcare professionals.
The Vietnam Lifestyle Medicine Alliance (VLMA) is a physician-led professional platform focused on evidence-based Lifestyle Medicine, professional education and scientific knowledge exchange. VLMA is not a licensed medical examination or treatment facility and does not independently provide clinical kidney care, individualized therapeutic nutrition, medical prescriptions or dialysis services.
International guidelines, evidence reviews and professional frameworks cited in this article are provided for educational purposes. They do not automatically have regulatory force in Viet Nam or expand the legally authorized professional scope of any individual or organization.
Vietnam Lifestyle Medicine Alliance
Evidence-Based Lifestyle Medicine for Viet Nam.
Contact
contact@vlma.org
Saigon Paragon Building, No. 3 Nguyen Luong Bang Street, Tan My Ward, HCMC
+84 909 228 476
+84 84 9999 911
© 2025 - 2026. Vietnam Lifestyle Medicine Alliance. All rights reserved.
A physician-led professional platform advancing Lifestyle Medicine through education, collaboration, research, and responsible implementation.
VLMA is operated by Vietnam Lifestyle Medicine Alliance Company Limited, Enterprise Registration Number 0318902666.
VLMA is a Sister Organization of the Lifestyle Medicine Global Alliance and a Member Organization of the Planetary Health Alliance.
VLMA is not a medical service provider and does not issue medical licenses or IBLM certification.
